top of page
Placeholder.jpg
Ingenuity Path Analysis (IPA)

Overview of the product

QCIF is proud to support Queensland’s biomedical research community through a statewide shared license for QIAGEN Ingenuity Pathway Analysis (IPA), a powerful bioinformatics tool that enables researchers to interpret complex omics data by mapping it to known biological pathways and networks.


Through this license, researchers will gain access to IPA’s proprietary Knowledge Base, a repository of expertly curated biological interactions and functional annotations created from peer-reviewed literature. This resource provides high quality, biologically insights that go beyond raw data found in public databases.


IPA also supports access to its Knowledge Base through an intuitive, user-friendly interactive interface with functionalities like upstream regulator prediction and causal network modelling, enabling researchers to explore and understand the biological relevance of their findings more effectively.


With these capabilities, IPA supports the discovery of molecular mechanisms, identification of biomarkers, and prediction of downstream effects, ultimately accelerating scientific discovery across health and life sciences.


Staff and students from participating Queensland universities can register to access QIAGEN Ingenuity Pathway Analysis (IPA) via QCIF via our contact form.

MEET OUR TEAM
The Team Behind the Product

Nicholas Matigian

Head, Bioinformatics

RECENT NEWS
Product Updates

28 August 2025

Statewide access to Ingenuity Pathway Analysis (IPA) accelerates biomedical research in Queensland

QCIF is proud to support Queensland’s biomedical research community through a statewide shared license for QIAGEN IPA.

bottom of page